Print Options

Font size:

← Back to notecard set|Easy Notecards home page

To print: Ctrl+PPrint as notecards

Biochem 19

1.

Two hormones primarily keep blood glucose near 80–100 mg/dL and coordinate fuel storage/mobilization:
A. Insulin and cortisol
B. Insulin and glucagon
C. Glucagon and epinephrine
D. Insulin and growth hormone

B. Insulin and glucagon

2.

After a high-carbohydrate meal, plasma insulin is typically highest at:
A. 5–10 minutes
B. 15–20 minutes
C. 60–90 minutes
D. 30–45 minutes

D. 30–45 minutes

3.

Intertissue metabolic homeostasis is achieved in three principal ways; which is NOT one of them?
A. Lymphatic metabolite signaling
B. Blood nutrient concentration
C. Hormonal messaging
D. CNS neural control

A. Lymphatic metabolite signaling

4.

Major determinant of whether skeletal muscle oxidizes fatty acids vs glucose:
A. Plasma lactate level
B. Hepatic glycogen content
C. Plasma fatty acid level
D. Portal glucagon level

C. Plasma fatty acid level

5.

Adult minimum daily glucose requirement is best matched by:
A. 190 total, 150 brain, 40 others
B. 150 total, 80 brain, 70 others
C. 100 total, 40 brain, 60 others
D. 190 total, 100 brain, 90 others

A. 190 total, 150 brain, 40 others

6.

Injected glucagon increases hepatic output but not skeletal muscle metabolism because muscle:
A. Uses only ketones
B. Degrades cAMP rapidly
C. Lacks glucagon receptors
D. Lacks pancreatic blood flow

C. Lacks glucagon receptors

7.

Physiologic targets of glucagon include:
A. Brain and muscle
B. Liver and adipose
C. Kidney and bone
D. Muscle and heart

B. Liver and adipose

8.

Poorly controlled diabetes causes weight loss despite appetite because:
A. Increased glycogen storage
B. Reduced FA oxidation
C. Increased glucose entry
D. Lipids become main fuel

D. Lipids become main fuel

9.

Marked hyperglycemia causes polyuria → dehydration → higher glucose; the initial urine increase is from:
A. Osmotic diuresis
B. Water diuresis
C. Pressure natriuresis
D. Tubular necrosis

A. Osmotic diuresis

10.

Confusion and seizures during severe hypoglycemia are:
A. Cholinergic manifestations
B. Neuroglycopenic manifestations
C. Osmotic manifestations
D. Myopathic manifestations

B. Neuroglycopenic manifestations

11.

Tremor, palpitations, and sweating during hypoglycemia are driven mostly by:
A. Cortisol
B. Glucagon
C. Epinephrine
D. Insulin

C. Epinephrine

12.

Correct islet hormone pairing:
A. α:glucagon β:insulin
B. α:insulin β:glucagon
C. α:amylin β:glucagon
D. α:insulin β:somatostatin

A. α:glucagon β:insulin

13.

Islet hormones enter the liver first via:
A. Splenic vein
B. Inferior vena cava
C. Thoracic duct
D. Hepatic portal vein

D. Hepatic portal vein

14.

Insulin is considered anabolic because after carbohydrate ingestion it promotes:
A. Lipolysis and ketogenesis
B. Glycogenolysis plus gluconeogenesis
C. Fuel use; fat and glycogen storage
D. Proteolysis and ketone use

C. Fuel use; fat and glycogen storage

15.

Insulin and glucagon are synthesized in islet cells as:
A. Steroids
B. Prohormones
C. Amines
D. Eicosanoids

B. Prohormones

16.

Preproinsulin is converted to proinsulin in the:
A. Rough ER
B. Golgi
C. Cytosol
D. Secretory granules

A. Rough ER

17.

During proinsulin folding, disulfide bonds form between:
A. Lysine residues
B. Serine residues
C. Histidine residues
D. Cysteine residues

D. Cysteine residues

18.

After folding and disulfide formation, proinsulin is transported to the:
A. Nucleus
B. Mitochondria
C. Golgi complex
D. Peroxisome

C. Golgi complex

19.

Proteolysis in storage vesicles produces insulin plus:
A. C-peptide
B. Signal peptide
C. Protein kinase A
D. cAMP

A. C-peptide

20.

Within storage vesicles, insulin is precipitated with:
A. Ca2+
B. Zn2+
C. Fe3+
D. Mg2+

B. Zn2+

21.

Biologically active insulin consists of:
A. Single chain, no bonds
B. Three chains, peptide links
C. Two chains, peptide bond
D. Two chains, disulfide links

D. Two chains, disulfide links

22.

Insulin binding triggers receptor autophosphorylation and downstream protein phosphorylation through the receptor’s:
A. Serine kinase domain
B. GPCR domain
C. Tyrosine kinase domain
D. Guanylyl cyclase domain

C. Tyrosine kinase domain

23.

Glucagon raises cAMP, which activates PKA to:
A. Phosphorylate regulatory enzymes
B. Dephosphorylate regulatory enzymes
C. Cleave C-peptide
D. Insert GLUT4 channels

A. Phosphorylate regulatory enzymes

24.

Compared with glucagon, insulin generally shifts key enzymes toward:
A. Increased phosphorylation
B. Increased cAMP
C. Increased PKA activity
D. Increased dephosphorylation

D. Increased dephosphorylation

25.

Recurrent fasting hypoglycemia with inappropriately high insulin suggests a tumor producing excess insulin called:
A. Glucagonoma
B. Insulinoma
C. Somatostatinoma
D. VIPoma

B. Insulinoma

26.

During IV glucose, β-cell uptake primarily uses:
A. GLUT1
B. GLUT2
C. GLUT4
D. SGLT2

B. GLUT2

27.

In β-cells, glucose → glucose-6-phosphate via:
A. Hexokinase I
B. PFK-1
C. Glucose-6-phosphatase
D. Glucokinase

D. Glucokinase

28.

β-cell glycolysis→TCA→OXPHOS most directly increases:
A. ATP levels
B. IP3 levels
C. NADPH levels
D. cAMP levels

A. ATP levels

29.

Teen with new DKA has near-zero insulin. Best mechanism?
A. Increased hepatic insulin clearance
B. Peripheral insulin resistance
C. Autoimmune β-cell destruction
D. Excess autonomic vagal tone

C. Autoimmune β-cell destruction

30.

Type 1 DM susceptibility is linked to HLA coding:
A. MHC II
B. MHC I
C. CD8 co-receptor
D. TCR beta chain

A. MHC II

31.

Fasting hypoglycemia suggests insulinoma. As glucose falls:
A. Insulin falls appropriately
B. Insulin rises despite low glucose
C. Insulin becomes undetectable
D. Glucagon falls despite stress

B. Insulin rises despite low glucose

32.

Approximate glucose threshold for insulin release:
A. 50 mg/dL
B. 60 mg/dL
C. 70 mg/dL
D. 80 mg/dL

D. 80 mg/dL

33.

Insulin is rapidly removed primarily by:
A. Skeletal muscle
B. Liver
C. Brain
D. Pancreas

B. Liver

34.

Cephalic-phase insulin release is enhanced by:
A. Somatic motor efferents
B. Dorsal root afferents
C. Vagus parasympathetic signals
D. Corticospinal tract firing

C. Vagus parasympathetic signals

35.

Post-meal hormones that augment early insulin release:
A. GIP and GLP-1
B. Secretin and motilin
C. CCK and gastrin
D. Ghrelin and leptin

A. GIP and GLP-1

36.

MODY can result from mutations in:
A. GLUT4 translocation proteins
B. Glucagon receptor subunits
C. Glucokinase or transcription factors
D. Insulin degradation enzymes

C. Glucokinase or transcription factors

37.

MODY2 glucokinase mutation reduces activity via:
A. Lower Km and higher Vmax
B. Higher Km and higher Vmax
C. Lower Km and lower Vmax
D. Higher Km or lower Vmax

D. Higher Km or lower Vmax

38.

Neonatal diabetes presents within the first:
A. Two weeks
B. First three months
C. First twelve months
D. First two years

B. First three months

39.

Most common mutation in permanent neonatal diabetes:
A. KCNJ11
B. HLA-DQ
C. PFKM
D. GLUT4

A. KCNJ11

40.

A KATP channel stuck open impairs insulin because:
A. ATP cannot be generated
B. GLUT2 cannot transport glucose
C. Proinsulin cannot fold
D. Ca2+ influx stays low

D. Ca2+ influx stays low

41.

Glucagon is cleared by liver/kidney; half-life is:
A. 30–60 minutes
B. 10–20 minutes
C. 3–5 minutes
D. 1–2 hours

C. 3–5 minutes

42.

Islet blood flow carries insulin:
A. δ→β across islet
B. β→α across islet
C. α→β across islet
D. Uniform bidirectional mixing

B. β→α across islet

43.

Glipizide increases insulin secretion by:
A. Opening KATP channels
B. Blocking Ca2+ channels
C. Closing KATP channels
D. Inhibiting hepatic insulinase

C. Closing KATP channels

44.

High insulin with absent C-peptide suggests:
A. Exogenous insulin use
B. Insulinoma secretion
C. MODY2 glucokinase defect
D. Type 2 insulin resistance

A. Exogenous insulin use

45.

Primary defect in type 2 diabetes mellitus:
A. Autoimmune β-cell destruction
B. Absent insulin receptor synthesis
C. Defective portal vein delivery
D. Insulin resistance in tissues

D. Insulin resistance in tissues

46.

In diabetes, glucagon may remain elevated due to:
A. Excess insulin feedback
B. Alpha-cell insulin resistance
C. Complete liver failure
D. Increased β-cell blood flow

B. Alpha-cell insulin resistance

47.

NOT a plasma-membrane signaling mechanism:
A. Nuclear receptor transcription
B. Adenylate cyclase → cAMP
C. Receptor kinase activity
D. PIP2 hydrolysis coupling

A. Nuclear receptor transcription

48.

Insulin receptor component spanning into cytosol:
A. Alpha subunit
B. C-peptide chain
C. Beta subunit
D. HLA subunit

C. Beta subunit

49.

After insulin binding, phosphorylated IRS-1 recruits via:
A. PDZ domains
B. SH3 domains
C. WD repeats
D. SH2 domains

D. SH2 domains

50.

Increased amino acid uptake into skeletal muscle primarily reflects which insulin action?
A. Growth factor–mediated protein synthesis
B. Stimulation of glucose and amino acid transport
C. Reverses glucagon phosphorylation
D. Alters enzyme gene expression

B. Stimulation of glucose and amino acid transport

51.

A patient takes a methylxanthine PDE inhibitor. Which metabolic pattern is most expected?
A. Fed-state fuel storage
B. Fasted-state fuel mobilization
C. Ketone suppression
D. Glycolysis inhibition

B. Fasted-state fuel mobilization

52.

A patient develops tachycardia after sympathetic surge. The dominant cardiac adrenergic receptor is:
A. β1 receptor
B. β3 receptor
C. α1 receptor
D. β2 receptor

A. β1 receptor

53.

The major agonist stimulating the heart’s dominant β-receptor is:
A. Dopamine
B. Epinephrine
C. Norepinephrine
D. Acetylcholine

C. Norepinephrine

54.

A hepatic cell increases glycogenolysis via an adrenergic receptor class most associated with fuel mobilization. Which receptor?
A. β3 receptor
B. β2 receptor
C. α1 receptor
D. β1 receptor

B. β2 receptor

55.

Which catecholamine is a much more potent β2 agonist?
A. Epinephrine
B. Norepinephrine
C. Dopamine
D. Acetylcholine

A. Epinephrine

56.

Activation of β2 receptors also mediates vascular, bronchial, and uterine smooth muscle ______.
A. Contraction
B. Necrosis
C. Calcification
D. Fibrosis

A. Contraction

57.

A drug aimed at increasing thermogenesis in adipose tissue would target:
A. α1 receptor
B. β2 receptor
C. β1 receptor
D. β3 receptor

D. β3 receptor

58.

β3 receptor activation most directly increases:
A. Fatty acid oxidation
B. Glycolysis rate
C. Glycogen synthesis
D. Protein catabolism

A. Fatty acid oxidation

59.

Postsynaptic receptors mediating vascular contraction via Gq/PLCβ use:
A. cAMP cascade
B. PIP2 pathway
C. JAK-STAT signaling
D. Guanylyl cyclase

B. PIP2 pathway

60.

In a healthy person after a high-carb meal, insulin peaks at 30–45 minutes and returns to basal by:
A. 30 minutes
B. 6 hours
C. 2 hours
D. 24 hours

C. 2 hours

61.

Two insulin polypeptide chains are linked by:
A. Glycosidic bonds
B. Phosphodiester bonds
C. Peptide bonds
D. Disulfide bonds

D. Disulfide bonds

62.

The insulin chain containing an additional intrachain disulfide bond is the:
A. β chain
B. A (α) chain
C. B (β) chain
D. Connecting peptide

B. A (α) chain

63.

Increased β-cell glucose metabolism raises ATP:ADP, which first leads to:
A. Opening KATP channels
B. Closing KATP channels
C. Closing Ca2+ channels
D. Opening Cl− channels

B. Closing KATP channels

64.

Closure of β-cell KATP channels most directly causes:
A. Membrane hyperpolarization
B. Membrane depolarization
C. Ribosomal translocation
D. MHC II expression

B. Membrane depolarization

65.

Insulin is rapidly cleared primarily by the:
A. Liver
B. Brain
C. Pancreas
D. Skin

A. Liver

66.

Preproglucagon processing yields mature 29–AA glucagon plus:
A. GLP-1 and GLP-2
B. Insulin and amylin
C. C-peptide and zinc
D. IRS-1 and SH2

A. GLP-1 and GLP-2

67.

After a high-protein meal, amino acids typically cause glucagon to:
A. Fall below fasting
B. Normalize immediately
C. Remain high or increase
D. Become undetectable

C. Remain high or increase

68.

During fasting-feeding cycles, which hormone varies more?
A. Glucagon
B. Insulin
C. Cortisol
D. Epinephrine

B. Insulin

69.

In a binding assay using intact insulin receptors, the subunit that binds insulin is:
A. β subunit, cytosolic tail
B. α subunit, cytosolic tail
C. α subunit, extracellular domain
D. β subunit, extracellular domain

C. α subunit, extracellular domain

70.

A mutation truncating the receptor’s cytosolic kinase region most directly affects which subunit?
A. β subunit, transmembrane/cytosolic
B. α subunit, extracellular binding
C. α subunit, nuclear translocation
D. β subunit, secreted peptide

A. β subunit, transmembrane/cytosolic

71.

Minutes after insulin binds, the earliest receptor event is:
A. Serine phosphorylation of enzymes
B. cAMP synthesis by adenylate cyclase
C. PIP2 hydrolysis via Gq
D. Tyrosine autophosphorylation of β

D. Tyrosine autophosphorylation of β

72.

In insulin signaling, the principal substrate phosphorylated by the receptor is:
A. CREB
B. IRS-1
C. Phosphodiesterase
D. Phospholamban

B. IRS-1

73.

After IRS-1 phosphorylation, docking occurs through proteins containing:
A. SH2 domains
B. PH domains
C. PDZ domains
D. SH3 domains

A. SH2 domains

74.

A hormone receptor that activates adenylate cyclase to raise cAMP is best classified as:
A. Receptor tyrosine kinase
B. Nuclear transcription receptor
C. GPCR
D. Ligand-gated ion channel

C. GPCR

75.

The glucagon receptor most directly couples to which G-protein?
A. Gi
B. Gs
C. Gq
D. G12/13

B. Gs

76.

In hepatocytes, glucagon binding most directly increases:
A. IP3
B. DAG
C. cGMP
D. cAMP

D. cAMP

77.

cAMP activates PKA by:
A. Dephosphorylating catalytic subunits
B. Phosphorylating regulatory subunits
C. Dissociating regulatory from catalytic
D. Opening membrane calcium channels

C. Dissociating regulatory from catalytic

78.

After activation, PKA phosphorylates key enzymes mainly on:
A. Serine residues
B. Tyrosine residues
C. Threonine residues
D. Cysteine residues

A. Serine residues

79.

The phosphorylated-enzyme message is primarily terminated by:
A. Adenylate cyclase inhibition
B. Gs binding GDP
C. SH2 domain sequestration
D. Protein phosphatases removing phosphate

D. Protein phosphatases removing phosphate

80.

cAMP is rapidly degraded to AMP by:
A. Protein phosphatase 1
B. Membrane phosphodiesterase
C. Phospholipase Cβ
D. Guanylyl cyclase

B. Membrane phosphodiesterase

81.

Caffeine increases cAMP primarily by inhibiting:
A. Protein phosphatases
B. Adenylate cyclase
C. Phosphodiesterase
D. Tyrosine kinase

C. Phosphodiesterase

82.

A methylxanthine’s metabolic effect most closely mimics:
A. Postprandial insulin surge
B. Insulin-induced storage state
C. Low catecholamine tone
D. Fasted glucagon/epinephrine state

D. Fasted glucagon/epinephrine state

83.

A CRE-binding protein directly phosphorylated by PKA is:
A. IRS-1
B. CREB
C. GLUT2
D. KCNJ11

B. CREB

84.

CREs that mediate cAMP-hormone transcriptional effects are located in:
A. Promoter regions of genes
B. Ribosomal RNA operons
C. Mitochondrial DNA control region
D. Lysosomal membrane proteins

A. Promoter regions of genes

85.

Cortisol signaling is best summarized as:
A. GPCR → cAMP → PKA → gene expression
B. RTK → IRS-1 docking → gene expression
C. Gq → PIP2 hydrolysis → gene expression
D. Intracellular receptor binding → nucleus → gene expression

D. Intracellular receptor binding → nucleus → gene expression

86.

Overall, catecholamines primarily cause:
A. Fuel storage predominance
B. Glycogen synthesis predominance
C. Increased fuel mobilization
D. Reduced substrate availability

C. Increased fuel mobilization

87.

β-adrenergic receptors generally signal through:
A. Gq and PLCβ
B. Gs and adenylate cyclase
C. Gi and ion channels
D. JAK-STAT pathway

B. Gs and adenylate cyclase

88.

The major adrenergic receptor in human heart and its primary agonist:
A. β1; norepinephrine
B. β2; norepinephrine
C. β3; epinephrine
D. α1; epinephrine

A. β1; norepinephrine

89.

The adrenergic receptor prominent in liver/muscle fuel mobilization, with epinephrine > norepinephrine potency:
A. β1 receptor
B. α1 receptor
C. β3 receptor
D. β2 receptor

D. β2 receptor

90.

Receptor that mediates vascular/bronchial/uterine smooth muscle contraction:
A. β1 receptor
B. α1 receptor
C. β2 receptor
D. β3 receptor

C. β2 receptor

91.

A candidate “weight-loss” agonist increasing thermogenesis would target:
A. β3 receptor
B. β2 receptor
C. α1 receptor
D. β1 receptor

A. β3 receptor

92.

Increased cardiac contraction with β1 stimulation is partly via PKA phosphorylation of:
A. CREB
B. Phospholamban
C. IRS-1
D. Phosphodiesterase

B. Phospholamban

93.

Only 30–40% of “glucagon” is mature; major extra-pancreatic source of fragments is:
A. Hepatocytes
B. Skeletal myocytes
C. Renal tubule cells
D. Intestinal L cells

D. Intestinal L cells

94.

A patient receives an α1 agonist and develops increased afterload. The primary postsynaptic α1 effect is:
A. Vascular smooth muscle contraction
B. Adipose thermogenesis increase
C. Insulin vesicle exocytosis
D. Bronchial smooth relaxation

A. Vascular smooth muscle contraction

95.

During sympathetic activation, α1 signaling in hepatocytes can directly increase:
A. Glycogen synthesis
B. Glucose uptake
C. Hepatic glycogenolysis
D. Ketone clearance

C. Hepatic glycogenolysis

96.

An α1 receptor couples into the PIP2 system. Which G-protein mediates this pathway?
A. Gi
B. Gq
C. Gs
D. G12/13

B. Gq

97.

In α1 signaling, activation of Gq most directly stimulates:
A. Protein phosphatases
B. Phosphodiesterase
C. Adenylate cyclase
D. Phospholipase Cβ

D. Phospholipase Cβ

98.

A clinic measures waist–hip ratio. A high value most strongly indicates:
A. Brown fat predominance
B. Gluteofemoral fat predominance
C. Visceral periintestinal adipocytes
D. No fat redistribution

C. Visceral periintestinal adipocytes

99.

Visceral periintestinal adipocytes fat distribution pattern is associated with diabetes risk because it correlates with:
A. Reduced insulin sensitivity
B. Increased insulin sensitivity
C. Increased glucagon clearance
D. Reduced catecholamine tone

A. Reduced insulin sensitivity

100.

A patient with uncontrolled diabetes reports polyuria and intense thirst. Which sequence best explains the mechanism described here?
A. ADH excess, water retention, edema
B. Tubular necrosis, oliguria, azotemia
C. SIADH physiology, hyponatremia, coma
D. Osmotic diuresis, dehydration, ↑glucose

D. Osmotic diuresis, dehydration, ↑glucose

101.

A newborn develops diabetes within the first 3 months. The most common permanent form involves an activating KCNJ11 mutation. What is the key functional consequence?
A. KATP closes, Ca2+ blocked
B. GLUT2 fails, ATP drops
C. KATP stays open, Ca2+ blocked
D. Insulin receptor absent, IRS-1 fails

C. KATP stays open, Ca2+ blocked

102.

Chronic hyperglycemia can distort membrane/serum proteins and slow degradation via:
A. Nonenzymatic glycosylation
B. Enzymatic hydroxylation
C. Proteasome hyperactivation
D. Mitochondrial uncoupling

A. Nonenzymatic glycosylation

103.

Which long-term complication cluster best fits microvascular diabetic disease?
A. Coronary stroke PAD
B. Aortic aneurysm dissection
C. Retinopathy nephropathy neuropathy
D. COPD asthma bronchiectasis

C. Retinopathy nephropathy neuropathy

104.

Which complication cluster best fits macrovascular diabetic disease in these notes?
A. Retinopathy, nephropathy, neuropathy
B. Coronary cerebral peripheral disease
C. Dermatitis, urticaria, eczema
D. Myopathy, arthropathy, osteopenia

B. Coronary cerebral peripheral disease

105.

After KATP channel closure in β-cells (by ATP or sulfonylurea), which event most directly triggers insulin vesicle fusion with the membrane?
A. Increased intracellular Ca2+
B. Decreased intracellular cAMP
C. Increased IP3 signaling
D. Reduced ATP:ADP ratio

A. Increased intracellular Ca2+

106.

The pore-forming unit of the β-cell KATP channel is encoded by:
A. HLA
B. KCNJ11
C. ABCC8
D. CREB

B. KCNJ11

107.

The regulatory subunit that binds sulfonylureas is encoded by:
A. ABCC8
B. KCNJ11
C. PEPCK
D. IRS-1

A. ABCC8

108.

Connie has fasting hypoglycemia with inappropriately high insulin; symptoms improve after eating. Most likely diagnosis:
A. Type 1 diabetes
B. Addison disease
C. Insulinoma
D. MODY type 2

C. Insulinoma

109.

Confusion, fatigue, and blurred vision during hypoglycemia are classified as:
A. Osmotic manifestations
B. Cholinergic manifestations
C. Musculoskeletal manifestations
D. Neuroglycopenic manifestations

D. Neuroglycopenic manifestations

110.

Why is C-peptide useful for assessing β-cell function?
A. Secreted only with exogenous insulin
B. Equimolar secretion, slower clearance
C. Rapidly cleared faster than insulin
D. Produced only by α-cells

B. Equimolar secretion, slower clearance

111.

MODY patients can still produce/release insulin, but typically require:
A. Severe hypoglycemia
B. Basal fasting glucose
C. Higher glucose levels
D. Low catecholamines

C. Higher glucose levels

112.

Glucagon can increase PEPCK gene transcription via cAMP. Insulin antagonizes this at gene expression via:
A. CRE in promoter
B. IRE in promoter
C. SH2 docking site
D. PIP2 response element

B. IRE in promoter

113.

Insulin receptor mediates internalization of receptor-bound insulin molecules. This causes what pharmacologic phenomenon?
A. Receptor sensitization
B. Second-messenger amplification
C. Gq coupling switch
D. Receptor downregulation

D. Receptor downregulation